Group III phospholipase A2 downregulation attenuated survival and metastasis in ovarian cancer and promotes chemo-sensitizationUpasana Ray, Viji Shridhar, Grace Cullen et al.|Journal of Experimental & Clinical Cancer Research|2021Cited by 25
Abstract 2706: Inhibition of PFKFB3/glycolysis overcomes chemoresistance in ovarian cancersSusmita Mondal, Viji Shridhar, Debarshi Roy et al.|Cancer Research|2015Cited by 1
Arachidonic Acid Signaling in Invasive and Non-Invasive Breast Cancer CellsDebarshi Roy|DigitalCommons@UTEP (The University of Texas at El Paso)|2012Cited by 0
Abstract B74: Can we repurpose anti-malarial drug quinacrine to treat ovarian cancer?Debarshi Roy, Viji Shridhar, Ashwani Khurana et al.|Clinical Cancer Research|2016Cited by 0
Abrogation of group III phospholipase A2 inhibits tumor growth and metastasis in ovarian cancer and promotes chemo-sensitizationUpasana Ray, Viji Shridhar, Krista M. Goergen et al.|Research Square|2021Cited by 0